That is essential, due to the fact that the way a protein in the body folds determines if a pharmaceutical will have the ability to bind to that protein and be efficient. To put it simply, we have to know how these proteins fold if we want a drug to work. Historically, this has actually been a trial-and-error procedure (jeff brown). But now, Alpha, Fold can forecast protein folding with 92. 4% accuracy. That's going to make it a lot easier to create drugs that do what they're created to do. This was a development practically nobody noticed. However it's going to have profound implications for treating disease. I predict that Alpha, Fold will be 98% accurate by the end of 2021.
And, naturally, there will be plenty of financial investment chances in this area, too. Shifting topics It's going to be an excellent year for bitcoin. I'm bullish on it in 2021 (black sea). That said, I still believe bitcoin will continue to be unpredictable. We're close to all-time highs. I wouldn't be surprised if it pulled back maybe considerably prior to going higher - democratic republic. I've been covering bitcoin for a very long time now. Among the very first research reports I ever published was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that initial recommendation, I titled my report "What's the Big Deal With Bitcoin?" That shows you where the discussion was at the time. We were primarily informing readers. However that's not the big concern anymore. Now we're seeing institutional cash finally take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, specific niche business. Mass, Mutual is a relied on 170-year-old institution. So think about that. In five years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
Which's a huge factor I'm bullish on it this year. tech predictions. Regards, Jeff Brown, Editor, The Bleeding Edge I have a reward prediction 2020 was a record year for IPOs. 552 U.S. business went public the most in more than twenty years. These business raised a total of $172 billion. That's an all-time high beating the previous annual record by 43%. I predict 2021 will be another record year in IPOs. There are so many fantastic private business on the brink of hitting the public markets And I've been dealing with a new way for you to invest even before these companies go public.
This opportunity has actually been developing over the last couple of years. I can't wait to tell you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to discover all the details. Go right here to book your area free of charge.
Emma Walsh here, handling editor of the Diary. Routine Diary readers understand that tech isn't our typical beat (white house). And when it pertains to tech investing, we leave it to the experts. The good news is, we have a number of such specialists in our Rolodex. Our associate Jeff Brown will recognize to our long time readers. He is one of the most accomplished tech investing professionals we understand (jeff brown stock predictions). In truth, he had several triple-digit returns in his Brownstone Research portfolios in 2015. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to take a look at the big picture and predict what's just around the corner.
That includes things like 5G networks, biotech, synthetic intelligence, and much more. These patterns are experiencing rapid growth and producing incredible opportunities for financiers. I desire to make certain all our readers are gotten ready for what's next. And with that in mind, let me draw the picture of what I see coming in the next 12 months Our brand-new 5G (fifth-generation) wireless networks are a topic I have actually been covering for years now. jeff brown biotech stock. But in spite of what lots of readers may think, this is a trend that's just starting. Despite the fact that the COVID-19 pandemic interrupted supply chains in 2015, an outstanding 250 million 5G-enabled gadgets were still offered.
And all of this eventually caused Apple postponing the release of the 5G-enabled i, Phone 12 by two months (tech predictions). Losing 2 months of manufacturing and sales truly affects how many 5G devices are offered in the calendar year. When you consider all of that, selling 250 million units is exceptional. More notably, the delays brought on by the pandemic developed a ton of pent-up demand. Which demand is now going to be pressed into 2021. In fact, I predict that more than 500 million 5G gadgets will be delivered in 2021 - biotech stocks jeff brown. Which's not my only 5G forecast When I've spoken about 5G in the past, I've explained its three various stages.
In Phase Two, 5G gadgets go on sale. 5G phones and other products begin to reach consumers. And in Stage Three, 5G services begin to be offered (jeff brown genome sequencing stock). That's when we begin to see applications operating on 5G networks. Consider things like massive multiplayer games over a mobile phone. That's not possible with 4G. It will be with 5G. And my second 5G forecast for 2021 is that we will begin Phase Three by this summer. This starts something of a virtuous cycle: Many individuals don't truly care about the technology. But they will care if there are exciting applications that can only be accessed with a 5G phone.
That leads to more 5G apps being established. In reality, 5G is going to open a suite of unbelievable applications: self-driving cars, the Internet of Things, robotic surgery, and more. All of these technologies require 5G. The investment chances moving forward will be enormous. Stepping away from 5G, the next crucial innovation I anticipate in 2021 is CRISPR hereditary modifying. CRISPR represents "clustered frequently interspaced short palindromic repeat." It's a mouthful. But it is among the most interesting advancements in biotechnology. At a high level, CRISPR is a technology that can modify our genetic makeup as if it were software application.
The program can crash or not operate correctly. CRISPR utilizes a comparable concept however with our genetic code. "Typos" in our genome can result in disease. CRISPR can remedy these "typos." For many years, CRISPR was primarily a niche innovation that wasn't well understood. And throughout that time, there were really only 3 companies operating in this space. However things are changing. CRISPR is no longer just theoretical. We're seeing actual outcomes. We're dealing with diseases and seeing that this technology simply works. And as a result, a "2nd crop" of early-stage CRISPR business is going public and providing incredible returns. This whole market is successfully a greenfield opportunity.
There's room for lots of business to exist in this area. genetic sequencer stock jeff brown. And there will be more. That's my prediction for CRISPR in 2021. I forecast that two or three more genetic modifying business will hold their IPOs. Sticking with biotechnology, we are seeing incredible things taking place at the convergence of biotech and synthetic intelligence (AI). Google's AI subsidiary, Deep, Mind, simply revealed at the end of 2020 that its newest Alpha, Fold software application can properly anticipate the folding of a protein based exclusively on its amino acid series with 92. 4% accuracy. That is essential due to the fact that the method a protein in the body folds determines if a pharmaceutical will have the ability to bind to that protein and be effective.
Historically, this has been an experimental process. And now, Alpha, Fold can forecast protein folding with 92. 4% precision. That's going to make it a lot easier to develop drugs that do what they're designed to do. And here's my next prediction. I anticipate that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not simply one but numerous drug treatments produced using this innovation. This was one of those breakthroughs that nearly no one discovered. However it's going to have extensive implications for curing disease. And, of course, there will be plenty of financial investment chances in this area, too.
It's going to be an excellent year for bitcoin. I'm bullish on it in 2021. That said, I still believe bitcoin will continue to be volatile. We're close to all-time highs. I would not be amazed if it drew back perhaps significantly before going greater. I have actually been covering bitcoin for a long period of time now. Among the very first research study reports I ever released was on bitcoin - jeff brown prediction for 2021. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on investment for anybody who followed my recommendation. However at the time of that initial recommendation, I entitled my report, "What's the Big Offer With Bitcoin?" That shows you where the discussion was at the time.
However no one is asking that concern anymore. Now, we're seeing institutional cash finally taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, niche business. toxic tech 5 tech darlings. Mass, Mutual is a 150-year-old organization. So consider that. In five years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a huge reason I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another reward prediction In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown deserves about $27. 5 million and declares the info is up to date as of February 2021, but we could not individually validate this claim. Offered Jeff Brown's past, he likely has a significant net worth, however we can't hammer down a precise figure at this moment. Brown is best known for his sage-like ability to choose winning innovation stocks. He invested more than 25 years looking into technology business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's extensive experience offers him an outstanding viewpoint on the market. He's always on the hunt for new opportunities, and he shares much of his best choices in the Near Future Report.
That's high praise, but it's not absurdly reasoned. Brown has an excellent reputation as a stock-picker, and he effectively predicted a few of the most significant economic events of the previous twenty years. Although he does not appear to release his picks to the public, the service's success is a direct indication of Brown's stock-picking prowess. Nobody on Wall Street gets it ideal each time, however Jeff Brown's precise forecasts have actually made him legions of dedicated followers. That states a lot about his ability. The Near Future Report is released by Brownstone Research, a prominent monetary research study publisher. Brownstone Research provides numerous research services with a wide range of expertises - jeff bezos.
The company is also affiliated with Bonner & Partners, another well-respected research publisher - artificial intelligence. On its site, Brownstone says its objective is to supply retail financiers with professional-grade research study: "For too long, the finest financial investment research has actually not been readily available to individual financiers. It has been usually reserved for financial investment banks, hedge funds, private equity, and high-net-worth clients. jeff brown genetic sequencing stock. The mission of Brownstone Research is to make that sort of exclusive research study available to any investors seeking to acquire an edge in the markets. The objective is basic to deliver special and rewarding financial investment research study discovered nowhere else." -Brownstone Research site excerpt from the Jeff Brown is the creator of Brownstone Research, and he also serves as the firm's Chief Investment Expert.
With Brown assisting the ship, Brownstone Research study is a powerhouse publisher with lots to offer its customers. After decades of stable success at the helm of top-tier companies like Tesla and Area, X, Elon Musk is a family name throughout the majority of America. If you know even a bit about the marketplace, you know that he has a track record as a King Midas of sorts. jeff brown stock predictions. Everything he touches turns to gold! Jeff is aware of Elon Musk's executive prowess, so he constantly has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next huge job.
In truth, Brown believes S.A.V. tech stock. could be "the greatest trend of the 2020s, and he's not alone. Check out these quotes from other well-known S.A.V. bulls: Elon's next huge act will be marrying 2 cutting-edge technologies: expert system and electric cars and trucks. Musk hopes the combination will help him establish the first fully-autonomous, self-driving cars and trucks ever. It's nothing except the automobile industry's Holy Grail. As you know, electrical cars and self-driving cars and truck stocks have actually been substantial this year, but the Wall Street machine has actually been big on buzz without much concrete outcome. Regardless of an extreme increase in competitors over the previous few years, Brown still thinks Musk has the very best possibility of putting it all together.
tech might be the magic string that connects everything together. S.A.V. means Shared Autonomous Car, and it might be the future of transport. Generally, this technology would allow you to lease your cars and truck as a self-governing, self-driving taxi when you're not using it. You just get out of the vehicle and press a button on an app that tells the automobile to "join the fleet." Next thing you understand, you're unwinding on your sofa while your car shuttles ride-sharers around town. Best of all, you get to keep a significant chunk of the earnings. It sounds outrageous, however it could be closed than you believe.